Peptide Stack
A peptide stack is a combination of two or more research peptides used together in a protocol to study potential synergistic effects. A common example is BPC-157 combined with TB-500.
Overview
Stacking refers to the deliberate combination of peptides that may target complementary pathways, with the hypothesis that their combined effect exceeds what either would produce individually. The BPC-157 and TB-500 stack is frequently cited in research literature because BPC-157 targets local tissue repair signaling while TB-500 (Thymosin Beta-4 fragment) promotes systemic cell migration and angiogenesis. Similarly, CJC-1295 (a GHRH analogue) is commonly stacked with Ipamorelin (a GHRP) to stimulate growth hormone release via two separate receptor pathways simultaneously. When studying stacks, researchers must account for potential interactions, overlapping receptor targets, and combined dose calculations.
Related Terms
Frequently asked questions
Why stack peptides instead of using just one?+
Some peptides act on different receptors or pathways that may complement each other. Stacking is studied to determine whether combining compounds produces effects neither achieves alone.
What is the most common peptide stack in research?+
BPC-157 + TB-500 for tissue repair and CJC-1295 + Ipamorelin for growth-hormone-axis research are among the most frequently cited stacks in preclinical literature.
Do stacked peptides interact with each other chemically?+
When administered separately (as separate injections), the peptides do not directly interact chemically. Their combined effects occur at the receptor and signaling level rather than in the syringe.